Cansortium (Fluent)
A Florida-headquartered multi-state cannabis operator that sells branded medical and adult-use products under the Fluent retail banner.
Cansortium is a mid-sized US multi-state operator best known for its Fluent dispensaries in Florida. It's a real, licensed, publicly traded company — not a folk brand — but like most MSOs it has cycled through losses, restructurings, and consolidation talks. Treat marketing claims about potency, product purity, or 'craft' cultivation the same way you'd treat any retailer's: verify on the certificate of analysis and your state's license lookup, not the press release.
What it is
Cansortium Inc. is a Canadian-domiciled, US-operating cannabis company that does business primarily under the Fluent consumer brand. It operates as a vertically integrated cannabis company, meaning it cultivates, processes, and sells its own products through company-owned dispensaries rather than relying on third-party retailers [1][2].
The company traces its roots to Knox Medical, an early Florida medical marijuana license holder, and rebranded its retail footprint to Fluent as it expanded [3]. It trades on the Canadian Securities Exchange under the symbol TIUM.U and files public disclosures there [1].
Cansortium is not a 'legacy' or craft brand — it is a licensed commercial operator built around state medical-cannabis license regimes.
Ownership and corporate structure
Cansortium Inc. is the publicly traded parent. As of public filings reviewed for this profile, it is not a subsidiary of a larger MSO, though the US cannabis sector has seen frequent merger activity and the company has publicly explored strategic transactions [1][4].
In 2024, Cansortium and fellow Florida operator RIV Capital announced a proposed merger that would have combined the two companies; that deal was reported on in trade and financial press [4][5]. Readers should check current SEC-equivalent filings on SEDAR+ for the company's present ownership and any completed or terminated transactions [1]. Strong evidence
No claim is made here about ultimate beneficial owners beyond what appears in those public filings.
Market and category focus
Cansortium's center of gravity is Florida medical marijuana, where Fluent operates a chain of dispensaries serving qualified patients under the state's Medical Marijuana Use Registry program [2][6]. Florida's regime requires vertical integration: licensed Medical Marijuana Treatment Centers (MMTCs) must grow, process, and dispense their own product, which structurally shapes how Cansortium operates [6].
The company has also disclosed operations or licenses in additional states including Pennsylvania and Texas at various points [1][3]. State footprints in the US cannabis industry change frequently due to license sales, market exits, and regulatory action, so the list of states where Fluent is actually open today should be confirmed on the company's own store locator and the relevant state regulator's licensee list, not from older articles.
Notable products and services
Under the Fluent banner, the company sells the typical range of state-legal medical cannabis formats: flower, pre-rolls, vape cartridges, concentrates, tinctures, capsules, and topicals [2][3]. Product availability, formats, and THC limits vary by state law — Florida, for example, has specific rules and historical caps on smokable flower and THC concentration that have shifted over time [6].
This profile does not recommend specific products. Cannabinoid content, terpene profiles, and quality vary batch to batch even within a single brand, and the only reliable check is the certificate of analysis (COA) for the specific lot you're buying. See Certificate of Analysis for how to read one.
Reputation, awards, and controversies
Cansortium and Fluent have received some industry coverage and trade-press recognition over the years, but cannabis industry awards are generally sponsor-driven and not independently audited Disputed. Treat 'award-winning' marketing language with the same skepticism you'd apply to any consumer-goods category.
On the financial side, Cansortium — like most public US cannabis operators — has reported recurring net losses and has undertaken restructurings, layoffs, and asset reviews disclosed in its public filings [1][4]. This is typical of the sector and not unique to this company, but it is relevant context when evaluating long-term claims about availability or expansion.
No specific product-safety recall against Fluent is asserted here. Florida's Department of Health publishes MMTC actions and any recalls; readers wanting to verify the company's regulatory record should check the state's Office of Medical Marijuana Use directly [6].
Availability and legal-market notes
Fluent dispensaries operate inside state-licensed medical (and where applicable adult-use) markets. They do not ship cannabis products across state lines — interstate commerce in cannabis remains federally illegal in the United States regardless of state law [7]. Any third-party site claiming to ship Fluent-branded THC products nationwide should be treated as illegitimate or counterfeit.
Florida voters considered, and in November 2024 rejected, Amendment 3, which would have legalized adult-use cannabis in the state; as of this profile's last-checked date, Florida remains a medical-only market, which directly affects who can legally buy from Fluent there [8]. Strong evidence
What to verify before relying on brand claims
Before treating any claim about Cansortium or Fluent as current fact, check:
- Licensing: Look up the operator on the relevant state regulator's licensee list (e.g., Florida OMMU) [6].
- Corporate status: Check current filings on SEDAR+ for Cansortium Inc. to confirm it is still publicly traded and to see the latest annual and quarterly disclosures [1].
- Product specifics: Demand the lot-specific COA for cannabinoid content, terpene profile, and contaminant testing. Marketing claims about strain lineage, 'craft' cultivation, or potency are not independently verified by regulators in most states Weak / limited.
- Store locations: Use the company's own locator; trade-press lists go stale quickly.
- Ownership changes: Merger and acquisition activity in this sector is constant. Any 'parent company' claim more than a few months old should be re-checked.
Profile last checked: 2025.
Sources
- Government Canadian Securities Administrators. SEDAR+ public filings for Cansortium Inc.
- Reported MJBizDaily. Coverage of Cansortium Inc. and Fluent operations (various dates).
- Reported Marijuana Business Daily. 'Knox Medical rebrands as Fluent Cannabis Care.'
- Reported Green Market Report. Coverage of the proposed RIV Capital–Cansortium merger, 2024.
- Reported MJBizDaily. 'RIV Capital, Cansortium agree to merge in stock deal' (2024).
- Government Florida Department of Health, Office of Medical Marijuana Use. Medical Marijuana Treatment Center licensing and program information.
- Government US Drug Enforcement Administration. Controlled Substances Act scheduling of marijuana.
- Reported Associated Press. 'Florida voters reject recreational marijuana amendment' (November 2024).
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Curaleaf — A US-headquartered multi-state cannabis operator that owns the Select and Grassroots brand...
- Trulieve Cannabis Corp. — A US multi-state cannabis operator best known for its dominant retail and cultivation foot...